Luspatercept and Lenalidomide (L2)
A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
Near Add Your Location
Sorting 7 by
Center of Excellence
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
The University of Texas Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, TX
- Accepting patients
Center of Excellence
- Not yet accepting
Center of Excellence
Weill Cornell
New York, NY
- Not yet accepting
Showing 1-7 of 7
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.